Summary Do GLP-1s work for PWS? Drs. Rubenstein and Stokes are surveying health records from 14,000 individuals living with PWS from 2014 to 2025 to identify which GLP-1s have been prescribed, how well they worked, and if there were any side effects.
Summary Drs. Roy and Bird will convene a panel of experts to develop guidelines for clinical care of neonates and infants with PWS.
The Foundation for Prader-Willi Research (federal tax id 31-1763110) is a nonprofit corporation with federal tax exempt status as a public charity under section 501(c)(3).
The mission of FPWR is to eliminate the challenges of Prader-Willi syndrome through the advancement of research and therapeutic development.
Copyright © 2020. All Rights Reserved. Terms of Use. Privacy Policy. Copyright Infringement Policy. Disclosure Statement.
